Management of COPD Flashcards

1
Q

What does COPD stand for

A

Chronic Obstructive Pulmonary Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is COPD

A

A combination of airflow obstruction and hyperinflation that is progressive and not fully reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name a cause of airflow obstruction

A

Chronic bronchitis which is not fully reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is chronic bronchitis

A

It causes thick sticky mucus to block up the airways and inflammation and swelling to further narrow the airway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name a cause of hyperinflation

A

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does emphysema cause

A

Air exchange to become difficult in damaged alveoli causing air to become trapped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name the symptoms of COPD

A

Breathlessness

Cough and recurrent chest infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name a cause of COPD

A

Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can smoking lead to the development of COPD

A

Tobacco in cigarettes releases a reactive oxygen species (‘free radicals’)
This causes the inactivation of antiproteases leading to an increase in neutrophil elastase
Tissue damage occurs leading to emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What other things can increase neutrophil elastase

A

Nicotine in tobacco
IL-8 and TNF from free radicals
Both cause the release of neutrophils causing an increase in neutrophil elastase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What can a cogenital α1AT deficiency cause to occur

A

Increase neutrophil elastase leading to tissue damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can an increase in macrophage elastase and metabolic proteinases lead to

A

Tissue damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some other outcomes of COPD (non-respiratory)

A

Loss of muscle mass
Weight loss
Cardiac disease
Depression, anxiety etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the two main respiratory illnesses which COPD can cause

A

Emphysema

Chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many people in the UK are affected with COPD

A

1 million with a further 2 million undiagnosed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How many people in the UK die from COPD

A

30,000

By 2020 it will be the 3rd leading cause of death in the UK although it is largely preventable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can COPD be diagnosis

A

Relevant history (symptoms)
Look for clinical signs
Confirmation of diagnosis and assessment of severity
Other relevant tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What type of symptoms will cause the suspicion of COPD

A
Patients aged 35 or more
Current or former smokers
Chronic cough
Exertional breathlessness
Sputum production
Frequent ‘winter’ bronchitis
Wheeze/chest tightness
19
Q

What are the differences between COPD and asthma

A

See table 3.5 in notes

20
Q

What features may be seen when examining for COPD

A
Early stages may be normal
Reduced chest expansion
Prolonged expiration/wheeze
Hyperinflated chest
Respiratory failure
21
Q

What features may be seen upon examination for respiratory failure

A
Tachypneoa
Cyanosis
Use of accessory muscles
Pursed lip breathing
Peripheral Oedema
22
Q

How can COPD be diagnosed

A

Through clinical history, examination and spirometry

23
Q

What will a clinical history show in COPD diagnosis

A

Cough
Breathlessness
Chest infections
Winter bronchitis

24
Q

What will an examination show in COPD diagnosis

A

May be normal
Tachypnoea
Wheeze
Hyperinflated chest

25
What will a spirometry do in COPD diagnosis
It will confirm the diagnosis and assess the severity
26
What does it mean if the FEV1 is over or equal to 80%
It is predicted to be mild
27
What does it mean if the FEV1 is between 50-79%
It is predicted to be moderate
28
What does it mean if the FEV1 is between 30-49%
It is predicted to be severe
29
What does it mean if the FEV1 is under 30%
It is predicted to be very severe
30
What are the baseline tests used for COPD
Spirometry which records absolute and % predicted values Chest X-ray ECG Full blood count (query anaemic/polycythaemic/eosinophilia) BMI (weight (kg)/height) AIAT if the age of onset is under 50
31
To prevent the onset of COPD what type of intervention should take place
Smoking cessation
32
To relieve breathlessness caused by COPD what type of intervention should take place
Use of inhalers
33
To prevent exacerbation from COPD what type of intervention should take place
Use of inhalers, vaccines, pulmonary rehabilitation (PR)
34
To manage the complications of COPD what type of intervention should take place
Long term oxygen therapy
35
What type of non-pharmacological managements can be provided
``` Smoking cessation Vaccinations (annual flu vaccine and pneumococcal vaccine) Pulmonary rehabilitation Nutritional assessment Psychological support ```
36
What are the benefits of pharmacological managements
Relieve of symptoms Prevention of exacerbations Improve the quality of life
37
Name three types of inhaled therapies
Short acting bronchodilators Long acting bronchodilators High dose inhaled corticosteroids (ICS) and LABA
38
Give examples of short acting bronchodilators
SABA (e.g. salbutamol) | SAMA (e.g. ipratropium)
39
Give examples of long acting bronchodilators
LAMA (Long acting anti – muscarinic agents e.g. umeclidinium, tioptropium etc) LABA (Long acting B2 agonist e.g. salmeterol)
40
Give examples of High dose inhaled corticosteroids (ICS) and LABA
Relvar (Fluticasone/vilanterol) | Fostair MDI
41
When is long term oxygen treatment (LTOT) given
When a persons PaO2 is below 7.3 kPa If they have a PaO2 between 7.3-8 kPa and have: nocturnal hypoxia, peripheral oedema, pulmonary hypertension or polycythaemia
42
Name some exacerbating factors of COPD
``` Increasing breathlessness Cough Sputum cough Sputum purulence Wheeze Chest tightness ```
43
What 4 methods can be used to manage AECOPD
Short acting bronchodilators Steroids Antibiotics Hospital admission if unwell
44
What investigations should be done for AECOPD (8)
Full blood count Biochemistry and glucose Theophylline concentration (in patients using theophylline preparation) Arterial blood gas (documenting the amount of oxygen given and by what delivery device) Electrocardiograph Chest X-ray Blood cultures in febrile patients Sputum microscopy, culture and sensitivity